|
PET along with the radiolabeled thymidine analog [18F]Fluorothymidine
(FLT) is “a promising, sensitive tool” for assessing drug effects on
tumor growth in patients with diffuse large B-cell lymphoma, according
to a study released at SNM’s 53rd Annual Meeting this week in San Diego.
|
|
more...
|